A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer

A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer

NCT00717951 ·Status: UNKNOWN ·Phase: PHASE2

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent

NCT00620100 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer

NCT00006120 ·Status: UNKNOWN ·Phase: PHASE2

Doxil/Caelyx BE Study

NCT05567601 ·Status: COMPLETED ·Phase: PHASE1

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

NCT01660542 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer

NCT01648608 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

NCT00050167 ·Status: COMPLETED ·Phase: PHASE1

Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer

NCT00365365 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Taxotere

NCT00206505 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

NCT00364611 ·Status: COMPLETED ·Phase: PHASE2

Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer

NCT00206453 ·Status: TERMINATED ·Phase: PHASE2

Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

NCT02041351 ·Status: COMPLETED ·Phase: PHASE2

A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer

NCT00214864 ·Status: COMPLETED ·Phase: PHASE2

Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer

NCT00274456 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer

NCT01227408 ·Status: WITHDRAWN ·Phase: PHASE2

Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

NCT04664972 ·Status: COMPLETED ·Phase: PHASE2

Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents

NCT00191438 ·Status: COMPLETED ·Phase: PHASE3

Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer

NCT00712881 ·Status: COMPLETED ·Phase: PHASE2

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

NCT05207514 ·Status: TERMINATED ·Phase: PHASE3

5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

NCT00434369 ·Status: UNKNOWN ·Phase: PHASE2

Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients

NCT07096869 ·Status: RECRUITING ·Phase: PHASE1

A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer

NCT01784120 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

NCT03221881 ·Status: COMPLETED ·Phase: NA

Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer

NCT02903524 ·Status: UNKNOWN ·Phase: PHASE4

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

NCT00005908 ·Status: COMPLETED ·Phase: PHASE2